Skip to content

Diagnostic Evaluation of Sarcopenia in Elderly Patients

Development of a New Sarcopenia Screening Tool in the Elderly

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04451005
Enrollment
403
Registered
2020-06-30
Start date
2016-05-06
Completion date
2019-12-10
Last updated
2020-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Keywords

Body composition, Sarcopenia, Elderly

Brief summary

Sarcopenia is a generalized progressive skeletal muscle disorder that represents a related physiological vulnerability that is associated with or increases the likelihood of adverse outcomes, including falls, fractures, physical disability and death. The parameters used to assess sarcopenia in clinical practice have limited use due to their custody. In this perspective, this study proposes or develops a tool for the diagnosis of having sarcopenia with a specific boa and a sensitive boa. low cost and useful. Elderly patients (n = 403) from the Geriatrics Outpatient Clinic of Hospital das Clínicas, Faculty of Medicine, University of São Paulo will be selected This study was of clinical importance, due to sarcopenia and a relevant factor, and could lead to consequences and poor prognosis in patients with gold, and it was not a method of clinical practice to properly endorse body composition in this population.

Detailed description

Sarcopenia is a progressive and generalized skeletal muscle disorder that represents an age-related physiological vulnerability that is associated with an increased likelihood of adverse outcomes, including falls, fractures, physical disability and mortality. The parameters used to assess sarcopenia in clinical practice have limited use due to its cost. In this perspective, this study proposes the development of a tool for the diagnosis of having sarcopenia with good specificity and good sensitivity and of low cost and useful. Elderly patients (n = 403) from the Geriatrics Outpatient Clinic of Hospital das Clínicas, Faculty of Medicine, University of São Paulo will be selected. After signing the informed consent, sarcopenia will be assessed using the reference method (DXA) and anthropometry. The data obtained by the methods are treated statistically to obtain correlation and thus a new tool for the evaluation of sarcopenia patients in the elderly can be developed. This study is of clinical importance, as sarcopenia is a relevant factor and can lead to consequences and poor prognosis in elderly patients, and there is no low-cost method in clinical practice to properly assess body composition in this population.

Interventions

OTHER0

Elderly patients with sarcopenia

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 60 years * Sign free and informed consent; * Demonstrate interest, conditions and availability to participate in all procedures included in the study protocol;

Exclusion criteria

* Refusal to participate; * Patients who have not undergone cognitive testing; * Physical amputation; * Patients undergoing interventional treatment for sarcopenia;

Design outcomes

Primary

MeasureTime frameDescription
Sarcopenia in the elderly12 monthsEvaluation of sarcopenia in the elderly

Secondary

MeasureTime frameDescription
Development of a new tool for sarcopenia screening12 monthsDevelopment of a new tool for sarcopenia screening

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026